Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

for the International Headache Society Clinical Trials Standing Committee

研究成果: Article同行評審

168 引文 斯高帕斯(Scopus)

摘要

Background: Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective: The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.

原文English
頁(從 - 到)815-832
頁數18
期刊Cephalalgia
38
發行號5
DOIs
出版狀態Published - 1 4月 2018

指紋

深入研究「Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults」主題。共同形成了獨特的指紋。

引用此